Patent: 6,890,904
✉ Email this page to a colleague
Summary for Patent: 6,890,904
| Title: | Anti-tumor agents |
| Abstract: | A method for treating subjects with abnormal cell proliferation is provided. The method involves administering to subjects in need of such treatment an effective amount of an agent of Formula I, to inhibit cell proliferation such as that associated with tumor growth and metastasis. A method for inhibiting angiogenesis in an abnormal proliferative cell mass by the administration of an agent of Formula I is also provided. |
| Inventor(s): | Wallner; Barbara P. (Cohasset, MA), Miller; Glenn (Merrimac, MA) |
| Assignee: | Point Therapeutics, Inc. (Boston, MA) |
| Application Number: | 09/578,363 |
| Patent Claims: | see list of patent claims |
Details for Patent 6,890,904
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Recordati Rare Diseases, Inc. | ELSPAR | asparaginase | For Injection | 101063 | 01/10/1978 | ⤷ Try a Trial | 2019-05-25 |
| Clinigen, Inc. | PROLEUKIN | aldesleukin | For Injection | 103293 | 05/05/1992 | ⤷ Try a Trial | 2019-05-25 |
| Servier Pharmaceuticals Llc | ONCASPAR | pegaspargase | Injection | 103411 | 02/01/1994 | ⤷ Try a Trial | 2019-05-25 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
